Vitreous VEGF Clearance Is Increased after Vitrectomy

被引:95
作者
Lee, Susan S. [1 ]
Ghosn, Corine [2 ]
Yu, Zhiling [2 ]
Zacharias, Leandro C. [3 ]
Kao, Henry [2 ]
Lanni, Carmine [2 ]
Abdelfattah, Natania [2 ]
Kuppermann, Baruch [3 ]
Csaky, Karl G. [4 ]
D'Argenio, David Z. [1 ]
Burke, James A. [2 ]
Hughes, Patrick M. [2 ]
Robinson, Michael R. [2 ]
机构
[1] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA
[2] Allergan Pharmaceut Inc, Irvine, CA 92715 USA
[3] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA USA
[4] Duke Eye Ctr, Durham, NC USA
关键词
DIABETIC MACULAR EDEMA; ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL TRIAMCINOLONE ACETONIDE; HEPARAN-SULFATE PROTEOGLYCANS; PARS-PLANA VITRECTOMY; NONVITRECTOMIZED EYES; PHARMACOKINETICS; INJECTION; MODEL; ANGIOGENESIS;
D O I
10.1167/iovs.09-3582
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
PURPOSE. Pars plana vitrectomy (PPV) has been reported to reduce macular thickness and improve visual acuity in patients with diabetic macular edema (ME). The hypothesis for the study was that after PPV, clearance is accelerated and VEGF concentrations are reduced. To test this hypothesis, hVEGF(165) injections were performed in rabbit eyes, with and without PPV, and vitreous VEGF levels were measured as a function of time. METHODS. The PPV group rabbits had a bilateral 25-gauge PPV, and in the no-PPV group, rabbits had intact vitreous. Intravitreal injections of hVEGF(165) were performed, and the animals were euthanatized at time points up to 7 days. The vitreous was isolated and an enzyme-linked immunosorbent assay was used to measure the VEGF levels. Pharmacokinetic parameters were determined in a noncompartmental analysis approach. RESULTS. Mean vitreous VEGF levels decreased more rapidly in eyes subjected to PPV than in no-PPV eyes. The vitreous VEGF half-life (t([1/2])) in PPV eyes was 10 times shorter than that in normal eyes. In addition, mean clearance and mean area under the curve (AUC) increased and decreased, respectively, in eyes that underwent PPV. CONCLUSIONS. VEGF clearance is increased after PPV. Reducing VEGF concentrations in the vitreous post-PPV may partially explain the improvement in macular thickness in some patients with ME. Unexpectedly, the half-life of VEGF in the vitreous, even in no-PPV eyes, was <3 hours, whereas compounds of similar molecular weight typically have longer vitreous half-lives. The back of the eye may be uniquely adapted with rapid-clearance mechanisms to regulate vitreous VEGF levels. Further study is suggested. (Invest Ophthalmol Vis Sci. 2010; 51: 2135-2138) DOI:10.1167/iovs.09-3582
引用
收藏
页码:2135 / 2138
页数:4
相关论文
共 40 条
[1]
INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY [J].
ADAMIS, AP ;
MILLER, JW ;
BERNAL, MT ;
DAMICO, DJ ;
FOLKMAN, J ;
YEO, TK ;
YEO, KT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) :445-450
[2]
VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[3]
Atkinson A.J., 2001, PRINCIPLES CLIN PHAR, P1
[4]
Pharmacokinetics of intravitreal ranibizumab (Lucentis) [J].
Bakri, Sophie J. ;
Snyder, Melissa R. ;
Reid, Joel M. ;
Pulido, Jose S. ;
Ezzat, Mohamed K. ;
Singh, Ravinder J. .
OPHTHALMOLOGY, 2007, 114 (12) :2179-2182
[5]
Pharmacokinetics of intravitreal bevackumab (avastin) [J].
Bakri, Sophie J. ;
Snyder, Melissa R. ;
Reid, Joel M. ;
Pulido, Jose S. ;
Singh, Ravinder J. .
OPHTHALMOLOGY, 2007, 114 (05) :855-859
[6]
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection [J].
Beer, PM ;
Bakri, SJ ;
Singh, RJ ;
Liu, WG ;
Peters, GB ;
Miller, M .
OPHTHALMOLOGY, 2003, 110 (04) :681-686
[7]
Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes [J].
Chin, HS ;
Park, TS ;
Moon, YS ;
Oh, JH .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (05) :556-560
[8]
DOFT BH, 1985, OPHTHALMOLOGY, V92, P1601, DOI 10.1016/S0161-6420(85)33838-1
[9]
Eckardt H, 2005, J BONE JOINT SURG BR, V87B, P1434, DOI 10.1302/0301-620X.87B10
[10]
Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown [J].
Edelman, JL ;
Lutz, D ;
Castro, MR .
EXPERIMENTAL EYE RESEARCH, 2005, 80 (02) :249-258